CAR-T targeting Igβ
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T targeting Igβ, covering 2022-04-05 to 2022-04-05. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma [Phase 2]